Victory Capital Management Inc. Sells 701 Shares of Henry Schein, Inc. (NASDAQ:HSIC)

Victory Capital Management Inc. decreased its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC) by 3.7% in the fourth quarter, Holdings Channel reports. The firm owned 18,241 shares of the company’s stock after selling 701 shares during the quarter. Victory Capital Management Inc.’s holdings in Henry Schein were worth $1,262,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Versant Capital Management Inc raised its stake in shares of Henry Schein by 274.6% in the fourth quarter. Versant Capital Management Inc now owns 457 shares of the company’s stock valued at $32,000 after acquiring an additional 335 shares during the last quarter. Venturi Wealth Management LLC raised its stake in shares of Henry Schein by 3,347.1% in the fourth quarter. Venturi Wealth Management LLC now owns 586 shares of the company’s stock valued at $41,000 after acquiring an additional 569 shares during the last quarter. Quent Capital LLC raised its stake in shares of Henry Schein by 91.2% in the fourth quarter. Quent Capital LLC now owns 677 shares of the company’s stock valued at $47,000 after acquiring an additional 323 shares during the last quarter. Smartleaf Asset Management LLC raised its stake in shares of Henry Schein by 23.2% in the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company’s stock valued at $52,000 after acquiring an additional 143 shares during the last quarter. Finally, City State Bank bought a new position in shares of Henry Schein in the fourth quarter valued at approximately $55,000. Institutional investors own 96.62% of the company’s stock.

Henry Schein Price Performance

HSIC opened at $70.84 on Thursday. The company has a fifty day moving average price of $74.84 and a two-hundred day moving average price of $72.62. The company has a debt-to-equity ratio of 0.46, a quick ratio of 0.82 and a current ratio of 1.42. Henry Schein, Inc. has a 52 week low of $63.67 and a 52 week high of $82.49. The firm has a market capitalization of $8.80 billion, a PE ratio of 29.15, a P/E/G ratio of 2.13 and a beta of 0.90.

Henry Schein (NASDAQ:HSIC) last released its earnings results on Tuesday, February 25th. The company reported $1.19 EPS for the quarter, missing analysts’ consensus estimates of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The business had revenue of $3.19 billion for the quarter, compared to analyst estimates of $3.25 billion. During the same period in the prior year, the firm posted $0.66 EPS. Henry Schein’s revenue was up 5.8% on a year-over-year basis. As a group, analysts anticipate that Henry Schein, Inc. will post 4.74 earnings per share for the current year.

Wall Street Analyst Weigh In

HSIC has been the subject of a number of research analyst reports. Wells Fargo & Company initiated coverage on shares of Henry Schein in a research note on Friday, February 14th. They issued an “equal weight” rating and a $80.00 target price for the company. Bank of America upgraded shares of Henry Schein from an “underperform” rating to a “buy” rating and lifted their target price for the company from $69.00 to $84.00 in a research note on Monday, January 6th. UBS Group lowered their price target on shares of Henry Schein from $83.00 to $80.00 and set a “neutral” rating for the company in a report on Wednesday, February 26th. Jefferies Financial Group raised their price target on shares of Henry Schein from $77.00 to $80.00 and gave the company a “hold” rating in a report on Thursday, January 23rd. Finally, Mizuho initiated coverage on shares of Henry Schein in a report on Wednesday, December 4th. They issued a “neutral” rating and a $75.00 price target for the company. Six analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat, Henry Schein has an average rating of “Moderate Buy” and an average target price of $81.10.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.